Sponsor
Atridia Pty Ltd.
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Atridia Pty Ltd. appears in 9 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
9 shownA Trial of HRS-6209-205 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-6209 in Combination Therapy in Subjects With HR-Positive/HER2-Negative CancerNCT07358377 · lead sponsor · 2026-05-15
RECRUITINGA Trial of HRS-5041-103 to Evaluate the Safety, Tolerability, Pharmacokinetics and Efficacy of HRS-5041 in Subjects With Metastatic Castration-resistant Prostate CancerNCT06830850 · lead sponsor · 2025-06-15
RECRUITINGA Trial of HRS-5817 in Obese ParticipantsNCT07238647 · lead sponsor · 2026-01-05
ACTIVE_NOT_RECRUITINGPhase 1 Study to Evaluate PK, Safety, and Tolerability of HRS-5041 in Healthy Caucasian Male ParticipantsNCT06559007 · lead sponsor · 2024-09-25
COMPLETEDA Trial of SHR-1707 Infusion in Patients With Mild Cognitive Impairment Due to Alzheimer's Disease and Mild Alzheimer's DiseaseNCT06114745 · lead sponsor · 2024-04-17
COMPLETEDA Trial of SHR-1905 in Healthy SubjectsNCT04800263 · lead sponsor · 2021-07-27
COMPLETEDA Trial of SHR-1703 in Healthy SubjectsNCT04855591 · lead sponsor · 2021-06-14
TERMINATEDA Trial of SHR-1707 in Healthy Young Adult and Elderly SubjectsNCT04745104 · lead sponsor · 2021-02-23
COMPLETEDA Phase 1 Trial of SHR3680 With or Without SHR3162 in Prostate CancerNCT02747342 · lead sponsor · 2016-09-01
COMPLETEDSponsor roles
lead sponsor9
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.